Shandong Xinhua Pharmaceutical Co Ltdの主要な財務諸表は何ですか?
最新の財務諸表(Form-10K)によると、Shandong Xinhua Pharmaceutical Co Ltdの総資産は$0で、純損失は$0です。
SHNXYの主要な財務比率は何ですか?
Shandong Xinhua Pharmaceutical Co Ltdの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Shandong Xinhua Pharmaceutical Co Ltdの収益はセグメントまたは地域別にどのように分けられていますか?
Shandong Xinhua Pharmaceutical Co Ltd の最大収益セグメントは Pharmaceutical Preparations で、最新の利益発表における収益は 3,985,519,069 です。地域別に見ると、China (including Hong Kong) が Shandong Xinhua Pharmaceutical Co Ltd の主要市場であり、収益は 6,785,211,744 です。
Shandong Xinhua Pharmaceutical Co Ltdは収益を上げていますか?
いいえ、最新の財務諸表によると、Shandong Xinhua Pharmaceutical Co Ltdの純損失は$0です。
Shandong Xinhua Pharmaceutical Co Ltdに負債はありますか?
いいえ、Shandong Xinhua Pharmaceutical Co Ltdの負債は0です。
Shandong Xinhua Pharmaceutical Co Ltdの発行済株式数は何株ですか?
Shandong Xinhua Pharmaceutical Co Ltdの総発行済株式数は0株です。
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
配当利回り
--
1株当たり利益(TTM)
--
時価総額
--
SHANDONG XINHUA PHARMACEUTICAL とは何ですか?
Shandong Xinhua Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zibo, Shandong and currently employs 7,240 full-time employees. Shandong Xinhua Pharmaceutical Co Ltd is a China-based company mainly engaged in the development, manufacturing and sales of chemical raw materials, pharmaceutical preparations and chemical products. The firm operates three segments. The Chemical Raw Materials segment is mainly engaged in the development, manufacturing and sales of raw materials for antipyretics and analgesics such as caffeine series, ibuprofen series, aspirin series, dopamine series, barbiturates and pipemidic acid. The Pharmaceutical Preparations segment is mainly engaged in the development, manufacturing and sales of tablets, injections and capsules such as pipemidic acid tablets, aminopyrine and nimodipine tablets. The Pharmaceutical Intermediates and Other Products segment is mainly engaged in the development, manufacturing and sales of pharmaceutical intermediates and other products. The firm mainly operates its business in the domestic market and overseas markets such as the Americas and Europe.